Helenalin

N/A

Report date: 2022/09/08 13:30:16

Base Information

Drug NameHelenalin
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H2 receptor antagonistsPhosphoric diester hydrolases inhibitorsDNA synthesis inhibitors
TargetsHistamine H2 receptorPhosphoric diester hydrolases
Therapy Area/IndicationsHeart FailureNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies +[1]  N/A
Active IndicationsN/A
Inactive IndicationsHeart FailureNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A